IF by specialty › Oncology
Journal of the National Cancer Institute — Impact Factor
The 2025 Impact Factor of Journal of the National Cancer Institute is 7.7 (Q1 in Oncology; subscription or hybrid).
- Impact Factor
- 7.7 JCR 2025
- JCR category
- Oncology
- Quartile
- Q1 in Oncology
- Publisher
- Oxford University Press
- Open access
- subscription or hybrid
- Abbreviations
- JNCI
- IF source
- bioxbio.com
Position within the field
Ranked 20 of the 42 journals in Oncology on this site (top 50%).
Oncology journals with a similar Impact Factor
- European Journal of Cancer IF 7.9
- British Journal of Cancer IF 7.8
- International Journal of Radiation Oncology, Biology, Physics IF 7.4
- Critical Reviews in Oncology/Hematology IF 6.2
- Gastric Cancer IF 6.1
- Radiotherapy and Oncology IF 5.8
About this value
Journal of the National Cancer Institute is abbreviated JNCI. The Journal Impact Factor of Journal of the National Cancer Institute (JCR 2025, released June 2026) is 7.7. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.